vs
Side-by-side financial comparison of HARROW, INC. (HROW) and OneSpan Inc. (OSPN). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $65.9M, roughly 1.4× OneSpan Inc.). OneSpan Inc. runs the higher net margin — 17.5% vs 7.4%, a 10.1% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 4.1%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 4.0%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.
HROW vs OSPN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $65.9M |
| Net Profit | $6.6M | $11.6M |
| Gross Margin | 79.3% | 73.6% |
| Operating Margin | 17.5% | 22.5% |
| Net Margin | 7.4% | 17.5% |
| Revenue YoY | 33.3% | 4.1% |
| Net Profit YoY | -2.2% | — |
| EPS (diluted) | $0.20 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $65.9M | ||
| Q4 25 | $89.1M | $62.9M | ||
| Q3 25 | $71.6M | $57.1M | ||
| Q2 25 | $63.7M | $59.8M | ||
| Q1 25 | $47.8M | $63.4M | ||
| Q4 24 | $66.8M | $61.2M | ||
| Q3 24 | $49.3M | $56.2M | ||
| Q2 24 | $48.9M | $60.9M |
| Q1 26 | — | $11.6M | ||
| Q4 25 | $6.6M | $43.5M | ||
| Q3 25 | $1.0M | $6.5M | ||
| Q2 25 | $5.0M | $8.3M | ||
| Q1 25 | $-17.8M | $14.5M | ||
| Q4 24 | $6.8M | $28.8M | ||
| Q3 24 | $-4.2M | $8.3M | ||
| Q2 24 | $-6.5M | $6.6M |
| Q1 26 | — | 73.6% | ||
| Q4 25 | 79.3% | 73.6% | ||
| Q3 25 | 75.3% | 73.6% | ||
| Q2 25 | 74.5% | 73.5% | ||
| Q1 25 | 67.5% | 74.3% | ||
| Q4 24 | 78.8% | 74.0% | ||
| Q3 24 | 75.6% | 73.9% | ||
| Q2 24 | 74.4% | 66.2% |
| Q1 26 | — | 22.5% | ||
| Q4 25 | 17.5% | 19.9% | ||
| Q3 25 | 20.6% | 14.4% | ||
| Q2 25 | 17.9% | 17.6% | ||
| Q1 25 | -23.5% | 27.1% | ||
| Q4 24 | 19.3% | 19.3% | ||
| Q3 24 | 2.7% | 20.0% | ||
| Q2 24 | 3.1% | 12.5% |
| Q1 26 | — | 17.5% | ||
| Q4 25 | 7.4% | 69.2% | ||
| Q3 25 | 1.4% | 11.4% | ||
| Q2 25 | 7.8% | 13.9% | ||
| Q1 25 | -37.2% | 22.9% | ||
| Q4 24 | 10.1% | 47.1% | ||
| Q3 24 | -8.6% | 14.7% | ||
| Q2 24 | -13.2% | 10.8% |
| Q1 26 | — | $0.39 | ||
| Q4 25 | $0.20 | $1.13 | ||
| Q3 25 | $0.03 | $0.17 | ||
| Q2 25 | $0.13 | $0.21 | ||
| Q1 25 | $-0.50 | $0.37 | ||
| Q4 24 | $0.19 | $0.73 | ||
| Q3 24 | $-0.12 | $0.21 | ||
| Q2 24 | $-0.18 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $49.8M |
| Total DebtLower is stronger | $250.0M | — |
| Stockholders' EquityBook value | $52.4M | $272.0M |
| Total Assets | $399.5M | $383.1M |
| Debt / EquityLower = less leverage | 4.77× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $49.8M | ||
| Q4 25 | $72.9M | $70.5M | ||
| Q3 25 | $74.3M | $85.6M | ||
| Q2 25 | $53.0M | $92.9M | ||
| Q1 25 | $66.7M | $105.2M | ||
| Q4 24 | $47.2M | $83.2M | ||
| Q3 24 | $72.6M | $77.5M | ||
| Q2 24 | $71.0M | $63.8M |
| Q1 26 | — | — | ||
| Q4 25 | $250.0M | — | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | — | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — |
| Q1 26 | — | $272.0M | ||
| Q4 25 | $52.4M | $271.8M | ||
| Q3 25 | $47.0M | $238.3M | ||
| Q2 25 | $49.7M | $242.5M | ||
| Q1 25 | $56.5M | $231.1M | ||
| Q4 24 | $69.7M | $212.5M | ||
| Q3 24 | $58.0M | $194.6M | ||
| Q2 24 | $58.5M | $178.6M |
| Q1 26 | — | $383.1M | ||
| Q4 25 | $399.5M | $397.7M | ||
| Q3 25 | $363.1M | $343.5M | ||
| Q2 25 | $345.0M | $357.1M | ||
| Q1 25 | $364.2M | $333.8M | ||
| Q4 24 | $389.0M | $338.7M | ||
| Q3 24 | $351.5M | $289.3M | ||
| Q2 24 | $306.6M | $286.9M |
| Q1 26 | — | — | ||
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $28.2M |
| Free Cash FlowOCF − Capex | $8.1M | — |
| FCF MarginFCF / Revenue | 9.1% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | 1.27× | 2.44× |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $28.2M | ||
| Q4 25 | $8.4M | $12.6M | ||
| Q3 25 | $16.6M | $11.3M | ||
| Q2 25 | $-803.0K | $6.2M | ||
| Q1 25 | $19.7M | $29.4M | ||
| Q4 24 | $-17.8M | $12.4M | ||
| Q3 24 | $3.0M | $14.0M | ||
| Q2 24 | $-2.7M | $2.3M |
| Q1 26 | — | — | ||
| Q4 25 | $8.1M | $9.6M | ||
| Q3 25 | $16.4M | $8.8M | ||
| Q2 25 | $-969.0K | $4.4M | ||
| Q1 25 | $19.5M | $27.7M | ||
| Q4 24 | $-18.3M | $10.5M | ||
| Q3 24 | $2.3M | $12.0M | ||
| Q2 24 | $-3.1M | $26.0K |
| Q1 26 | — | — | ||
| Q4 25 | 9.1% | 15.3% | ||
| Q3 25 | 22.9% | 15.4% | ||
| Q2 25 | -1.5% | 7.3% | ||
| Q1 25 | 40.8% | 43.8% | ||
| Q4 24 | -27.4% | 17.1% | ||
| Q3 24 | 4.8% | 21.4% | ||
| Q2 24 | -6.3% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 4.7% | ||
| Q3 25 | 0.3% | 4.4% | ||
| Q2 25 | 0.3% | 3.1% | ||
| Q1 25 | 0.4% | 2.6% | ||
| Q4 24 | 0.8% | 3.2% | ||
| Q3 24 | 1.2% | 3.5% | ||
| Q2 24 | 0.7% | 3.7% |
| Q1 26 | — | 2.44× | ||
| Q4 25 | 1.27× | 0.29× | ||
| Q3 25 | 16.26× | 1.74× | ||
| Q2 25 | -0.16× | 0.75× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | -2.62× | 0.43× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 0.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
OSPN
| Product and license | $35.5M | 54% |
| Services and other | $30.4M | 46% |
